Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7456187 Furanopyrimidine compounds as potassium ion channel inhibitors

Patent 7456187 was granted and assigned to Xention Limited on November, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Xention Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

74561870

Patent Inventor Names

John Frederick Atherall0

David John Madge0

John Ford0

Nicholas John Palmer0

Date of Patent

November 25, 2008

Patent Application Number

111489910

Date Filed

June 10, 2005

Patent Citations Received

‌

US Patent 11779604 Antibodies, combinations comprising antibodies, biomarkers, uses and methods

‌

US Patent 11753479 Nucleic acids encoding anti-OX40L antibodies

‌

US Patent 11773175 Antibodies, uses and methods

Patent Primary Examiner

‌

Brenda L Coleman

Patent abstract

A compound of formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7456187 Furanopyrimidine compounds as potassium ion channel inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API